Drug · DIN 02240229
STEMGEN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 31, 2012; first marketed September 20, 1999.
- Drug Identification Number (DIN)
- 02240229
- Company (DIN owner)
- Biovitrum Ab (Publ)Stockholm, Saone Et Loire, Sweden
- Schedule
- Prescription; Schedule d
- Dosage form
- Kit; Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Ancestim L03AA12
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
Notices of Compliance
Health Canada approvals that name this DIN.
- January 26, 2009: NOC 10007New Drug Submission (NDS) · Manufacturer name change
- May 20, 1999: NOC 1583New Drug Submission (NDS)
Other DINs named STEMGEN
- DIN 02240231 · Cancelled Pre Market